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Through evolution, enzymes have developed subtle modes of activation in order to ensure the sufficiently high substrate
specificity required by modern cellular metabolism. One of these modes is the use of a target-dependent module (i.e. a docking
domain) such as those found in signalling kinases. Upon the binding of the target to a docking domain, the substrate is
positioned within the catalytic site. The prodomain acts as a target-dependent module switching the kinase from an off state
to an on state. As compared to the allosteric mode of activation, there is no need for the presence of a third partner. None of
the ribozymes discovered to date have such a mode of activation, nor does any other known RNA. Starting from a specific on/
off adaptor for the hepatitis delta virus ribozyme, that differs but has a mechanism reminiscent of this signalling kinase, we
have adapted this mode of activation, using the techniques of molecular engineering, to both catalytic RNAs and DNAs
exhibiting various activities. Specifically, we adapted three cleaving ribozymes (hepatitis delta virus, hammerhead and hairpin
ribozymes), a cleaving 10-23 deoxyribozyme, a ligating hairpin ribozyme and an artificially selected capping ribozyme. In each
case, there was a significant gain in terms of substrate specificity. Even if this mode of control is unreported for natural
catalytic nucleic acids, its use needs not be limited to proteinous enzymes. We suggest that the complexity of the modern
cellular metabolism might have been an important selective pressure in this evolutionary process.
Citation: Le ´vesque D, Brie `re FP, Perreault J-P (2007) A Modern Mode of Activation for Nucleic Acid Enzymes. PLoS ONE 2(7): e673. doi:10.1371/
journal.pone.0000673
INTRODUCTION
Enzymes have evolved various versions of a ‘‘molecular switch’’
with which they control their catalytic activities. For example,
regulatory proteins bind effectors that induce conformational
changes that control catalytic activity [1]. Similar modes of
activation have been adopted by catalytic RNA motifs such as the
glmS riboswitch, a ribozyme that regulates gene expression in
a unique fashion through autocatalytic cleavage upon its binding
to glucosamine-6-phosphate [2,3]. Mitogen-activated protein
kinases (MAP kinases) have evolved a similar, but more subtle,
mode of activation [4,5]. Upon the binding of the target to
a docking domain, the substrate is positioned within the catalytic
site. The prodomain acts as a target-dependent module switching
the kinase from an off state to an on state, a property which
considerably improves the substrate specificity of the enzyme.
None of the ribozymes discovered to date exhibit such a mode of
activation, nor does any other known RNA. However, a Specific
On/ofF Adaptor (SOFA) module, which includes both a blocker
and a biosensor domain, has been developed for the hepatitis delta
virus (HDV) ribozyme [6,7]. The rationale behind this design was
that in the absence of the target, the ribozyme should be turned off
by the addition of a blocker domain (bl) that forms an
intramolecular stem with a portion of the substrate recognition
domain (stem P1; Figure 1A). Conversely, a biosensor domain (BS)
must bind its complementary sequence on the substrate in order to
unlock the catalytic core (turning on). In the SOFA module the
blocker and biosensor are juxtaposed, which is not the case for the
domain involved in the activation of MAP kinases. In the present
work, we have adapted this mode of activation, using the
techniques of molecular biology, to a wide range of catalysis types
exhibited by nucleic acids.
RESULTS
Development of a new on/off adaptor version for
HDV ribozyme
Initially, a new design that considers the blocker and biosensor
domains as distinct entities was performed by including them at
each end of the P2 stem of the HDV ribozyme in a process that
involved several steps (Figure 1B). First, a blocker sequence that
base-pairs with the binding domain of the ribozyme was added to
the 59-end. The resulting ribozyme exhibited no cleavage activity
with a model substrate derived from the internal ribosome entry
site (IRES) region of the hepatitis C virus (HCV) (Figure 1C, lane
3). The blocker acts as a ‘‘safety lock’’ placing the ribozyme in an
inactive conformation (off state). When the ribozyme possesses a 12
nucleotide (nt) biosensor sequence complementary to the substrate
at its 39-end, it exhibited an improved cleavage activity (Figure 1C,
lane 4). The presence of an inappropriate biosensor domain (i.e.
a sequence not complementary to the substrate) resulted in
a cleavage level comparable to that of the original ribozyme
(Figure 1C, lane 5). When an appropriate biosensor was added to
a ribozyme that already possessed a blocker, a dramatic increase in
the cleavage activity, as compared to that observed in the presence
of an inappropriate biosensor, was observed (Figure 1C, lanes 6
and 7, respectively). Thus, the ribozyme can be switched off and on
by independent domains in a way reminiscent of the MAP kinases.
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second order rate constants (kcat/KM’) as an indication of the
substrate specificities. The HDV on (i.e. the one including both
a blocker and an appropriate biosensor) exhibited a cleavage
activity characterized by a relative kcat/KM’ 6-fold higher than
that of the original ribozyme, which in turn had a value 12-fold
higher than that of the HDV off ribozyme (i.e the one including
a blocker and an inappropriate biosensor) (see Table 1). The
difference between the kcat/KM’ values of the off and on ribozymes
is therefore greater than 60 times. This difference is smaller than
the determined 1500 to 2500 times observed between the on and off
forms of the original configuration of the SOFA module on other
HDV ribozymes [6,7]. The larger difference in the latter case is
likely due to the fact that its configuration is probably better
adapted to the architecture of this particular ribozyme.
As the specificity of a ribozyme is commonly defined as its
ability to discriminate between similar substrates [1], a collection
of five substrates possessing identical ribozyme binding domains,
but different biosensor sequences, was synthesized (Figure 1D).
Because these substrates harbor different 59-ends, they can be
distinguished by their electrophoretic migration (Figure 1D, lane
1). When the 5 substrates were incubated together with only one
HDV on ribozyme, solely the substrate possessing the sequence
perfectly complementary to the biosensor was cleaved (Figure 1D,
lanes 2-6). Conversely, an original ribozyme (i.e. one without both
a biosensor and a blocker) had the ability to cleave all of the
substrates, although at different levels (Figure 1D, lane 7).
Together, these data demonstrate the improvement, in terms of
substrate specificity, resulting from the addition of both a blocker
and a biosensor. Moreover, it shows that a ribozyme, when
activated by the proper substrate, does not cleave other substrates
via a trans-cleavage mechanism. Finally, the potential to cleave
HCV-derived transcripts was tested in cell culture (data not
shown). Only small amounts of transcripts were cleaved. De-
termination of the half-life of the new conformation of the SOFA-
HDV ribozymes according to a procedure reported previously [8],
r
Figure 1. SOFA module on the HDV ribozyme. (A) Secondary structure
of both the off and on conformation of the SOFA module (in grey)
engineered on the P2 stem of the HDV ribozyme. The biosensor (BS, in
green) and the blocker (bl, in red) are juxtaposed. (B) Schematic
representation of separated blocker and biosensor domains modulating
the activity of a ribozyme in a substrate-dependent manner. (C)
Autoradiogram of cleavage assays performed with various HDV
ribozymes. Their structures, with both the biosensor (green) and the
blocker (red), are illustrated above the lanes of the gel. The control (-)
was performed in the absence of ribozyme (lane 1), while lane 2 was
performed in the presence of the original version. Lane 3 is the version
extended by the blocker sequence only. Lanes 4 and 5 are the versions
extended by a biosensor domain either complementary, or not, to the
substrate, respectively. Finally, lanes 6 and 7 are the on and off versions
including separated blocker and biosensor domains, respectively. BPB
and XC indicate the positions of the bromophenol blue and xylene
cyanol dyes, respectively. The nucleotide sequences of each of the
engineered ribozyme are shown in the Figure S1. (D) Verification of the
gain in substrate specificity of the trans-acting HDV ribozymes. The
upper portion shows a schematic representation of the substrates in
which the P1 binding domain is identical (grey), but the sequences of
the biosensors vary (different colors). The lower portion shows the
autoradiogram of a cleavage assay performed on a pool of substrates
either by a specific HDV on ribozyme (a to e correspond to the cleavage
produced by specific ribozymes, lanes 2 to 6, respectively), or by the
original ribozyme (lane 7). Lane 1 is the negative control performed in
the absence of ribozyme. The nucleotide sequences of each of
ribozyme are shown in the Figure S2.
doi:10.1371/journal.pone.0000673.g001
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likely by-product of the single-stranded extremities that these
ribozymes possess). More important is that it has been possible to
adapt the target-dependent module of activation from the MAP
kinase to the HDV ribozyme.
Adaptation of this mode of activation to various
cleaving nucleic acid enzymes
Subsequently, we tried to adapt this mode of activation to other
catalytic nucleic acids. As a first attempt, we chose three cleaving
molecules: the hammerhead ribozyme, the 10-23 deoxyribozyme
and the hairpin ribozyme (Figure 2) [9–11]. All of these nucleic
acid enzymes share a relatively similar architecture. The cleavage
site of the substrates is located in the middle of the two stems
formed between the catalytic center. The sequences of both of
these ribozymes and of the deoxyribozyme have been reported to
cleave various substrates that were used [12–15]. Each of these
catalytic nucleic acids showed significant cleavage of their 59-end
labelled substrates, although at different levels (Figure 2A–C, lane
2). The addition of a blocker domain that ‘‘zips off’’ the binding
domain dramatically decreased the cleavage activity (i.e.
Figure 2A–C, lane 3). As is observed with the biosensor-blocker
HDV ribozyme, the specificity of these engineered nucleic acid
molecules was dramatically increased through blocker-mediated
inactivation followed by reactivation via an extended complemen-
tarity with the appropriate biosensor sequence (Figure 2A–C, lanes
4 to 7). With both the biosensor and blocker domains, the presence
of an inappropriate biosensor locked the catalytic core into an off
state, while the presence of an appropriate biosensor permitted the
switch into the active mode, by displacing the blocker, solely in
presence of its specific substrate. The biosensors interact through
more base pairs than do the blockers, thereby favoring the on state
over the off state. When comparing the kcat/KM’ values for the off
and on versions of these catalytic molecules, the overall improve-
ments were of a minimum of three orders of magnitude (Table 1).
Specifically, the kcat/KM’ values vary from 2588-, 2762- and 9167-
folds between the off and on version of hammerhead ribozyme,
hairpin ribozyme and 10-23 deoxyribozyme, respectively. This
illustrates the important gain in terms of specificity. These
important differences were mainly the result of dramatic decreases
in the kcat values between those of the original structures and those
of their respective off states, suggesting that they lost their abilities
to perform non-specific cleavage. Importantly, the addition of both
a blocker and a biosensor permits the generation of cleaving
nucleic acid enzymes that operate in a target-dependent fashion.
Engineering ribozymes catalyzing various reactions
Next, we investigated other ribozyme’s catalyses. As a first
attempt, the ligation catalyzed by the hairpin ribozyme was
studied. Extending the 39-end of the original hairpin ribozyme by
6 nt resulted in the retention of the cleavage product, and
consequently favored the reverse reaction (Figure 3A) [14]. Using
a5 9-
32P-labelled RNA strand possessing a terminal 29-39-cyclic
phosphate and a second RNA strand possessing a 59-hydroxyl
resulted in the detection of ligation products (Figure 3B). The
addition of a biosensor with a sequence complementary to that of
the substrate increased the amount of ligation observed. In
contrast, the addition of the blocker module almost completely
abolished the ligation. Finally, an on version, which includes both
the blocker and an appropriate biosensor, exhibited a ligation
activity of up to 65%; while an off version (i.e. one with an
inappropriate biosensor) showed less than 5% activity.
Subsequently, the concept was adapted to an artificial ribozyme
that catalyzed the attack of a 59-terminal nucleotide phosphate on
the a-phosphate of the terminal triphosphate of an RNA substrate,
forming a 59-59 phosphodiester linkage (i.e. a capping ribozyme;
Figure 3C–D) [16]. A version harboring a blocker alone exhibited
only residual activity for the capping of a 33-nucleotide substrate
(,3%), while one possessing only an appropriate biosensor
sequence was slightly more efficient than the original. The on
version has the ability to switch from its off to on state, while the off
version remained trapped in the inactive conformation.
DISCUSSION
Together, these experiments demonstrate the possibility of
adapting the target-dependent activation concept to various types
of nucleic acid enzymes. The limiting factor with such an
adaptation is the fact that the suitable candidates need to have
a recognition mechanism based on base pair formation in order to
permit a rational design. As compared to the allosteric mode of
activation that has been engineered for synthetic nucleic acid
circuits based on oligonucleotide-sensing allosteric ribozymes and
deoxyribozyme [17–19], in this case there is no need for the
presence of a third partner.
Table 1. Kinetic parameters of four cleaving nucleic acid enzymes in single turnover conditions
..................................................................................................................................................
nucleic acid enzymes kcat (min
21)K M’ (nM) kcat/KM’ (min
21/M
21) relative kcat/KM’ values
HDV wt 0.2260.03 128637 1.7610
6 12
HDV on 0.1160.01 12639 . 2 610
6 66
HDV off 0.03460.004 240682 1.4610
5 1
hammerhead wt 0.07460.002 48681 . 5 610
6 1765
hammerhead on 0.1360.01 59624 2.2610
6 2588
hammerhead off 6.38610
2560.70610
25 75628 8.5610
2 1
deoxyribozyme wt 0.7660.08 211645 3.6610
6 1714
deoxyribozyme on 1.8060.12 312638 5.8610
6 2762
deoxyribozyme off 1.24610
2460.04610
24 60672 . 1 610
3 1
hairpin wt 0.4160.02 163622 2.5610
6 2083
hairpin on 0.1260.01 11621 . 1 610
7 9167
hairpin off 2.8610
2460.6610
24 2406155 1.2610
3 1
wt indicates wildtype
doi:10.1371/journal.pone.0000673.t001
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PLoS ONE | www.plosone.org 3 July 2007 | Issue 7 | e673As first glance it might appear somewhat surprising that any
known natural catalytic RNA would resort to this mode of
regulation in order to provide the appropriate substrate specificity.
This might be a mode of regulation for processes that require
additional selective pressures in order to ensure a greater fidelity of
action, for example as it is required for the MAP kinases. The
complexity of the modern cellular metabolism might have been an
important selective pressure in this evolutionary process. Catalytic
RNAs might not have needed to evolve such a regulation
mechanism due to the fact that their recognition strategy, which
is based on base pair formation, provided sufficient specificity.
Moreover, these ribozymes act in cis, therefore there is no
Figure 2. Autoradiograms of cleavage assays performed with
controlled cleaving nucleic acid enzymes. (A) (B) and (C) are the
reactions performed with the hammerhead ribozyme, the 10-23
deoxyribozyme and the hairpin ribozyme, respectively. In each case
the structures of the nucleic acid enzyme with the blocker (red) and
biosensor (green) are illustrated above the appropriate lanes of the gels,
and the control (-) was performed in the absence of any nucleic acid
enzyme (lane 1), and, lane 2, in the presence of the unmodified version
of the ribozyme. Lane 3 is the version extended by the blocker
sequence. Lanes 4 and 5 are the versions extended by a biosensor that
is either complementary, or not, to the substrate. Finally, lanes 6 and 7
are the on and off versions, respectively. The nucleotide sequences of
each nucleic acid enzyme are depicted in the Figures S3 to S5.
doi:10.1371/journal.pone.0000673.g002
Figure 3. Catalytic activity of the engineered dependent ligating and
capping ribozymes. (A) and (C) are the nucleotide sequences and
secondary structures of the ribozyme-substrate complexes of the ligating
hairpin and capping ribozymes, respectively. (B) and (D) are autoradio-
grams of thePAGE gels usedtoanalyse the ligation andcappingreactions,
respectively. The schematic structures of the nucleic acid enzymes with
both the blocker (red) and biosensor (green) are illustrated above the
appropriate lanes of the gels. The controls (-) was performed in the
absence of ribozyme (lane 1), and, lane 2, in the presence of the
unmodified versions. Lane 3 is the ribozyme extended by the blocker
sequence. Lanes 4 and 5 are the versions extended by a biosensor that is
either complementary, ornot,to the substrate, respectively. Finally,lanes 6
and 7 are the on and offribozymes, respectively. The nucleotide sequences
of each engineered nucleic acid enzyme are depicted in Figures S6 and S7.
doi:10.1371/journal.pone.0000673.g003
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PLoS ONE | www.plosone.org 4 July 2007 | Issue 7 | e673requirement for such mechanism. Other natural ribozymes, such as
the ribonuclease P [20], ribosome [21] and spliceosome [22],
catalyze their reactions with many substrates rendering high
substrate specificity detrimental. Alternatively, the ability of cis-
acting ribozymes to adopt different conformations may have
contributed to their regulation. For example, viroids self-cleave their
nascent transcripts through a hammerhead structure, but when the
polymerase progresses further, a sequence partially complementary
tothe self-cleavage motif issynthesized,and,consequently,a rod-like
structure is folded [23]. In this structure, the hammerhead motif is in
an off state that prevents cleavage after viroid circularization. Thus,
examples of RNA evolution that have already reached the blocker
step of this mode of activation do indeed exist. Here, we show that
a target-dependent activation, analogous to that of the MAP kinases,
is possible for a wide range of nucleic acid catalysis types. It is
therefore tempting to speculate that it already exists in nature, and
that it simply remains to be found.
MATERIALS AND METHODS
DNA templates and constructs
Deoxyribozymes were purchased as oligonucleotides from Invitro-
gen.Allribozymes and smallRNAsubstratesused wereproducedby
PCR using oligonucleotides purchased from either Invitrogen or
IDT Inc. Briefly, DNA oligonucleotides corresponding to the
sequences complementary to the different templates, and possessing
a T7 promoter complementary sequence, were annealed to T7
promoter primer and the primers extended in PCR reactions. The
reaction products were then used as templates for run-off
transcription (see below). Alternatively, some constructs were
prepared by annealing of two overlapping oligonucleotides that
were then filled in by PCR using Vent DNA polymerase (New
England Biolab), producing a double-stranded DNA fragment. Each
of these fragments was provided with a T7 promoter at the
beginning of the sense strand for subsequent use as a template for
run-off transcription. Hepatitis C virus (HCV) derived substrate (a
575 nt long template containing the internal ribosome entry site
(IRES)andthe first partofthe ORF)was produced byKpnId i g e s t i o n
of the pHCVA plasmid [6], which contains 1348 nt of the 59
sequence of hepatitis C virus (genotype 1b) [24]. PCR products and
linearized plasmid templates were purified by phenol/chloroform
extraction, precipitated with ethanol and dissolved in water.
RNA synthesis
Run-off transcriptions were performed as described previously [6].
Briefly, transcriptions were performed using purified T7 RNA
polymerase (10 mg) in the presence of RNA Guard (24 U,
Amersham Biosciences) and pyrophosphatase (0.01 U, Roche
Diagnostics) in a buffer containing 80 mM HEPES-KOH,
pH 7.5, 24 mM MgCl2, 2 mM spermidine, 40 mM DTT and
either linearized plasmid DNA (5 mg) or PCR product (100 pmol)
as template. Each NTP (5 mM) was added to the mixture either
with or without 50 mCi of [a-
32P]UTP (3 000 Ci/mmol, New
England Nuclear) in a final volume of 100 mL, and the reaction
incubated at 37uC for 2 to 4 h. Upon completion, the reaction
mixtures were treated with DNase RQ1 (Promega) at 37uC for
20 min, and the RNA then purified by phenol:chloroform
extraction and precipitation with ethanol. RNA products were
fractionated by a denaturing (7 M urea) 6 to 20% polyacrylamide
gel electrophoresis (PAGE; 19:1 ratio of acrylamide to bisacryla-
mide) using 45 mM Tris-borate, pH 7.5/1 mM EDTA solution as
running buffer. The reaction products were visualized either by
UV shadowing, or by autoradiography. The bands corresponding
to the correct sizes for both the ribozymes and the substrates were
excised from the gel and the transcripts eluted overnight at room
temperature in a buffer containing 1 mM EDTA, 0.1% SDS and
0.5 M ammonium acetate. The transcripts were ethanol pre-
cipitated at 280uC, washed, dried and dissolved in water. The
amounts retrieved were determined either by
32P counting, or by
absorbance at 260 nm.
In order to produce 59-labelled RNA substrates, transcripts were
dephosphorylated by adding 1 U of antartic phosphatase (New
England Biolab) to 20 pmol of RNA and incubating for 30 min at
37uC in a final volume of 10 mL containing 50 mM Tris-HCl,
pH 8.5, 0.1 mM EDTA and 40 U of RNAGuard (Amersham
Biosciences). The enzyme was inactivated by incubating at 65uCf o r
5 min. Dephosphorylated RNA (5 pmol) was then radiolabelled at
its 59-end using 3 U of T4 polynucleotide kinase in the presence of
3.2 pmol of [c-
32P]ATP (6000 Ci/mmol, New England Nuclear).
Radiolabelled transcripts were purified by electrophoresis on
a denaturing gel and recovered as described above.
Cleavage assays and kinetics
All reactions with the cleaving HDV, hammerhead and hairpin
ribozymes, as well as those with the deoxyribozyme, were
performed under single-turnover conditions ([Rz]..[S]) using
100 nM of nucleic acid enzyme and trace amounts of 59-
32P-
labelled substrates at 37uC in a final volume of 10 mL containing
50 mM Tris-HCl, pH 7.5 and 10 mM MgCl2. After an in-
cubation of 1 h, the reactions were quenched by the addition of
ice-cold formamide dye buffer (1 vol of 97% formamide, 10 mM
EDTA, pH 8.0, 0.25% xylene cyanol, 0.25% bromophenol blue)
and fractionated on 6% to 20% PAGE gels. The gels were then
analyzed with a radioanalytic scanner (Storm, Molecular Dynam-
ics). For time-course experiments, aliquots of 0.8 mL were taken at
various times up to 3 h and treated as described above. Kinetic
analyses were performed under single turnover conditions. Trace
amounts of 59-
32P-labelled substrate (,1 nM) were cleaved by
various concentrations of either ribozyme or deoxyribozyme (5–
400 nM). The fraction cleaved was determined, and the rate of
cleavage (kobs) obtained from fitting the data to the equation
At=A %(1-e
2kt) where At is the percentage of cleavage at time t,
A% is the maximum percent cleavage (or the end-point of
cleavage), and k is the rate constant (kobs). Each rate constant was
calculated from at least two independent measurements. The
values of kobs obtained were then plotted as a function of nucleic
acid enzyme concentration for the determination of kcat,K M’ and
kcat/KM’. The values obtained from independent experiments
varied by less than 15%. The experiments of substrate specificity
using several substrates were performed under multiple turnover
conditions using 100 nM HDV ribozyme and 1 mM substrate.
Ligation reactions
Ligation reactions were performed as described previously [14,15]
with minor modifications. Full length 59-
32P-labelled substrate
(5 pmol) was cleaved in the presence of 10 mM of hairpin ribozyme
in a volume of 50 ml containing 50 mM Tris-HCl, pH 7.5 and
10 mM MgCl2. The mixture was incubated 2 h at 37uC, quenched
by the addition of ice-cold formamide dye buffer, purified on a 20%
denaturing PAGE gel and the radiolabelled 20 nt 59-product
recovered as described. This RNA strand was then used as substrate
for theligation reaction. The 39-productusedinthisligation reaction
was purchased from IDT Inc. This deprotected 59-hydroxyl RNA
was purified as described above. Ligation reactions were performed
using 10 mM of the hairpin ribozyme in the presence of 15 mMo f
the 39-end substrate and trace amounts of 59-
32P-labelled substrate
mixed in a total volume of 9 ml containing 50 mM HEPES-KOH,
Nucleic Acid Enzyme Modulation
PLoS ONE | www.plosone.org 5 July 2007 | Issue 7 | e673pH 7.0. The reactions were preheated at 37uC for 10 min so as to
permit the annealing of the substrate to the ribozyme, and the
ligation reactions started (time=0) by adding 1 mL of 150 mM
MgCl2.Sampleswereincubatedat37uCfor1 h,fractionatedongels
and visualized by autoradiography.
Capping enzyme reaction
The capping reaction was performed as described previously [16].
Substrate was 39-end labelled by incubating, at 37uC, 10 pmol of
transcripts with 3.2 pmoles of [
32P]Cp (3000 ci/mmol, New
England Nuclear) and 1 U T4 RNA ligase (New England Biolab)
in the buffer supplied by the manufacturer supplemented with 10%
DMSO. After 3 h, the reaction was stopped and the transcripts
purified by denaturing 10% denaturing PAGE and recovered as
described above. Capping reactions were carried out under single
turnover conditions. Both the ribozyme (2 mM) and substrate
(0.2 mM) were annealed together for 5 min at 22uC in a reaction
buffer containing 50 mM Tris-HCl, pH 7.5, 25 mM MgCl2 and
150 mM KCl. The reactions were initiated by the addition of ATP
to a final concentration of 1 mM. After 16 h of incubation at 22uC,
the reactions were quenched by addition of ice-cold formamide dye
buffer and analyzed on denaturing 15% PAGE gels.
SUPPORTING INFORMATION
Figure S1 Nucleotide sequence and secondary structure of the
various versions of the HDV ribozyme cleaving a 28 nt substrate
derived from the hepatitis C virus. (A) The original version. (B) The
version including a 4 nt blocker (bl). (C) The version with an
appropriate 12 nt biosensor (BS). (D) The version with an
inappropriate 12 nt biosensor (iBS). (E) The on version with both
a blockerand an appropriate biosensor.(F) The off version with both
a blocker and an inappropriate biosensor (i.e. a biosensor of
sequence not complementary to the substrate). The blocker,
appropriate biosensor and inappropriate biosensor are in red, green
and grey, respectively. The arrows indicate the cleavage sites.
Found at: doi:10.1371/journal.pone.0000673.s001 (1.37 MB TIF)
Figure S2 Nucleotide sequence and secondary structures of the
HDV ribozyme-substrate complexes for the substrate specificity
experiment. All of the ribozymes and substrates possess the same P1
binding domain. (A) The original version of the HDV ribozyme
cleavinga28 ntsubstratederivedfromthehepatitisCvirus.(B)to(F)
The HDV on ribozymes with the different biosensor modules (in
different colors). (G) The original ribozyme that can bind all of the
substrates, regardless of their binding domains to the biosensor.
Found at: doi:10.1371/journal.pone.0000673.s002 (1.60 MB TIF)
Figure S3 Nucleotide sequence and secondary structure of the
hammerhead ribozyme cleaving a 575 nt substrate derived from
the HCV. (A) The original version as reported previously (12). (B)
The version including an 8 nt blocker (bl). (C) The version with an
appropriate 15 nt biosensor (BS). (D) The version with an
inappropriate biosensor (iBS). (E) The on version with both
a blocker and appropriate biosensor. (F) The off version with both
a blocker and an inappropriate biosensor. The blocker, appropri-
ate biosensor and inappropriate biosensor are in red, green and
grey, respectively. The arrows indicate the cleavage sites.
Found at: doi:10.1371/journal.pone.0000673.s003 (1.59 MB TIF)
Figure S4 Nucleotide sequence and secondary structure of the
10-23 deoxyribozyme cleaving a 46 nt substrate derived from the
59 UTR of the human rhinovirus 14. (A) The original version as
reported previously (13). (B) The version including an 8 nt blocker
(bl). (C) The version with an appropriate 14 nt biosensor (BS). (D)
The version with an inappropriate biosensor (iBS). (E) The on
version with both a blocker and an appropriate biosensor. (F) The
off version with both a blocker and an inappropriate biosensor.
The blocker, appropriate biosensor and inappropriate biosensor
are in red, green and grey, respectively. The arrows indicate the
cleavage sites.
Found at: doi:10.1371/journal.pone.0000673.s004 (1.18 MB TIF)
Figure S5 Nucleotide sequence and secondary structure of the
hairpin ribozyme cleaving a 44 nt substrate. (A) The original
version as reported previously (14). (B) The version including an
8 nt blocker (bl). (C) The version with an appropriate 11 nt
biosensor (BS). (D) The version with an inappropriate biosensor
(iBS). (E) The on version with both a blocker and appropriate
biosensor. (F) The off version with both a blocker and an
inappropriate biosensor. The blocker, appropriate biosensor and
inappropriate biosensor are in red, green and grey, respectively.
The arrows indicate the cleavage sites.
Found at: doi:10.1371/journal.pone.0000673.s005 (1.69 MB TIF)
Figure S6 Nucleotide sequence and secondary structure of the
hairpin ribozyme ligating two RNA strands 20 and 24 nt in length.
(A) The original version. (B) The version including a 6 nt blocker
(bl). (C) The version with an appropriate 11 nt biosensor (BS). (D)
The version with an inappropriate biosensor (iBS). (E) The on
version with both a blocker and appropriate biosensor. (F) The off
version with both a blocker and an inappropriate biosensor. The
blocker, appropriate biosensor and inappropriate biosensor are in
red, green and grey, respectively.
Found at: doi:10.1371/journal.pone.0000673.s006 (1.73 MB TIF)
Figure S7 Nucleotide sequence and secondary structure of the
ribozyme capping a 33 nt RNA strand by an ATP molecule as
reported previously (15). (A) The original version. (B) The version
including a 5 nt blocker (bl). (C) The version with an appropriate
10 nt biosensor (BS). (D) The version with an inappropriate
biosensor (iBS). (E) The on version with both a blocker and an
appropriate biosensor. (F) The off version with both a blocker and
an inappropriate biosensor. The blocker, appropriate biosensor
and inappropriate biosensor are in red, green and grey,
respectively.
Found at: doi:10.1371/journal.pone.0000673.s007 (1.93 MB TIF)
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